The DOI matches its Crossref record.
Clinical extracorporeal hybrid liver support – phase I study with primary porcine liver cells
Abstract
The objective of this study was to evaluate the feasibility and safety of a hybrid liver support system with extracorporeal plasma separation and bioreactor perfusion in patients with acute liver failure (ALF) who had already fulfilled the criteria for high urgency liver transplantation (LTx). Eight patients (one male, seven female) were treated in terms of bridging to transplantation. The mean age was 36.5 yr (range 20 to 58). Etiology of liver failure was drug‐related in two patients, hepatitis B infection in three patients, and unknown for three patients. The bioreactors were charged with primary liver cells from specific pathogen‐free pigs. Cell viability varied between 91 and 98%. Continuous liver support treatment over a period of 8 to 46 h (mean 27.3 h) was safely performed and well‐tolerated by all patients. No complications associated with the therapy were observed during the follow‐up period. Thrombocytopenia was considered to be an effect of the plasma separation. Subsequently, all patients were transplanted successfully and were observed over at least 3 yr with an organ and patient survival rate of 100%. Screening of patient's sera for antibodies specific for porcine endogenous retroviruses (PERVs) showed no reactivity – either prior to application of the system, or after extracorporeal treatment. The results encourage us to continue the development of the technology, and further studies appear to be justified. The bioreactor technology has been integrated into a modular extracorporeal liver support (MELS) system, combining biologic liver support with artificial detoxification technology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Acute liver failure: Summary of a workshop†
Lee, W. M., Squires, R. H., Nyberg, S. L., Doo, E., & Hoofnagle, J. H. (2008) · Hepatology · doi:10.1002/hep.22177 · Cited by 757
Lee, W. M., Stravitz, T. R., & Larson, A. M. (2012) · Hepatology · doi:10.1002/hep.25551 · Cited by 550
Infection Barriers to Successful Xenotransplantation Focusing on Porcine Endogenous Retroviruses
Denner, J., & Tönjes, R. R. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05011-11 · Cited by 208
Self-citationTsuruga, Y., Kiyono, T., Matsushita, M., Takahashi, T., Kasai, H., & Todo, S. (2008) · Cell Transplantation · doi:10.3727/096368908786991542 · Cited by 66
Diekmann, S., Bader, A., & Schmitmeier, S. (2006) · Cytotechnology · doi:10.1007/s10616-006-6336-4 · Cited by 32
Metadata
- Authors
- Sauer, I. M., Kardassis, D., Zeillinger, K., Pascher, A., Gruenwald, A., Pless, G., Irgang, M., Kraemer, M., Puhl, G., Frank, J., Müller, A. R., Steinmüller, T., Denner, J., Neuhaus, P., & Gerlach, J. C.
- Venue
- Xenotransplantation
- Publisher
- Wiley
- Published
- 2003-08-27
- Volume
- 10
- Issue
- 5
- Pages
- 460-469
- ISSN
- 0908-665X (ISSN-L)
- 1399-3089
- OpenAlex
- W2081437656
- Cited by
- 181
- References
- 0
- FWCI
- 11.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical extracorporeal hybrid liver support – phase I study with primary porcine liver cells. https://app.cochat.ai/papers/10.1034/j.1399-3089.2003.00062.x
- The paper
- Sauer, I. M., Kardassis, D., Zeillinger, K., Pascher, A., Gruenwald, A., Pless, G., Irgang, M., Kraemer, M., Puhl, G., Frank, J., Müller, A. R., Steinmüller, T., Denner, J., Neuhaus, P., & Gerlach, J. C. (2003). Clinical extracorporeal hybrid liver support – phase I study with primary porcine liver cells. Xenotransplantation. https://doi.org/10.1034/j.1399-3089.2003.00062.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.